angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Parkinson Disease

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harding, JW; Kawas, LH; Wright, JW	1
Grammatopoulos, TN; Hyman, BT; Outeiro, TF; Standaert, DG	1

Reviews

1 review(s) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Parkinson Disease

Article	Year
The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in neurobiology, 2015, Volume: 125 Topics: Alzheimer Disease; Angiotensin II; Animals; Humans; Memory Disorders; Parkinson Disease; Receptors, Angiotensin; Renin-Angiotensin System	2015

Other Studies

1 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Parkinson Disease

Article	Year
Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro. Biochemical and biophysical research communications, 2007, Nov-23, Volume: 363, Issue:3 Topics: alpha-Synuclein; Angiotensin II; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Humans; Imidazoles; Immunoblotting; Inclusion Bodies; Losartan; Parkinson Disease; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents	2007

Article

Year

Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro.

Biochemical and biophysical research communications, 2007, Nov-23, Volume: 363, Issue:3

Topics: alpha-Synuclein; Angiotensin II; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Humans; Imidazoles; Immunoblotting; Inclusion Bodies; Losartan; Parkinson Disease; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents

2007